Abstract:Zhisheng Huang, 1, 2 Zuowang Cheng, 3 Xia Deng, 4 Ying Yang, 5 Na Sun, 5 Peibin Hou, 5 Ruyue Fan, 5 Shuai Liu 6, 7 1 Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China; 2 Department of Pulmonary and Critical Care Medicine, National Regional Center for Respiratory Medicine, Jiangxi Hospital of China-Japan Friendship Hospital, Nanchang, Jiangxi, People's Republic of China; 3 Department of Clinical Laboratory, Zhangqiu District People's Hospital Affiliated to Jining Medical University, Jinan, Shandong, People's Republic of China; 4 School of Public Health, Shandong Second Medical University, Weifang, Shandong, People's Republic of China; 5 Shandong Center for Disease Control and Prevention, Jinan, Shandong, People's Republic of China; 6 Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China; 7 Shandong Key Laboratory of Infectious Respiratory Disease, Jinan, Shandong, People's Republic of China Correspondence: Shuai Liu; Ruyue Fan, Email ; Background: Coronavirus disease 2019 (COVID-19) is a respiratory infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The objective of this study is to identify reliable and accurate biomarkers for the early stratification of disease severity, a crucial aspect that is currently lacking for the impending phases of the next COVID-19 pandemic. Methods: In this study, we identified important module and hub genes related to clinical severe COVID-19 using differentially expressed genes (DEGs) screening combing weighted gene co-expression network analysis (WGCNA) in dataset GSE213313. We further screened and confirmed these hub genes in another two new independent datasets (GSE172114 and GSE157103). In order to evaluate these key genes' stability and robustness for diagnosing or predicting the progression of illness, we used RT-PCR validation of selected genes in blood samples obtained from hospitalized COVID-19 patients. Results: A total of 968 and 52 DEGs were identified between COVID-19 patients and normal people, critical and non-critical patients, respectively. Then, using WGCNA, 10 modules were constructed. Among them, the blue module positively associated with clinic disease severity of COVID-19. From overlapped section between DEGs and blue module, 12 intersected common differential genes were obtained. Subsequently, these hub genes were validated in another two new independent datasets as well and 9 genes that overlapped showed a highly correlation with disease severity. Finally, the mRNA expression levels of these hub genes were tested in blood samples from COVID-19 patients. In severe cases, there was increased expression of MCEMP1, ANXA3, CD177 , and SCN9A . In particular, MCEMP1 increased with disease severity, which suggested an unfavorable development and a frustrating prognosis. Conclusion: Using comprehensive bioinformatical analysis and the validation of clinical samples, we identified four major candidate genes, MCEMP1, ANXA3, CD177 , and SCN9A , which are essential for diagnosis or development of COVID-19. Keywords: COVID-19, differentially expressed genes, WGCNA, hub genes, neutrophil Over the past four years, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a worldwide health concern. As of 8 November 2023, there have been 771 million reported cases in 188 countries and territories, resulting in over 6.97 million deaths. 1 The disease can manifest in various degrees of severity, ranging from mild to critical. Moreover, emerging evidence suggests that individuals infected with SARS-CoV-2 can be asymptomatic carriers, contributing to the silent spread of the virus. 2,3 Despite extensive investigation, the underlying question of why there is such a marked difference in the disease progression among infected individuals remains unresolved. Current studies highlight that the illness severity and progression are largely determined by the dysregulated host inflammatory response. 4–6 When a virus penetrates a cell, it may activate both innate and adaptive host immune responses, which are critical components of viral defense. 7,8 The exaggerated or dysregulated inflammatory responses and an imbalanced adaptive immunity may account for severe tissue destruction. 9 The preexisting immunity on the response to vir -Abstract Truncated-

Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.

Potential Core Genes Associated with COVID-19 Identified Via Weighted Gene Co-Expression Network Analysis.

Identification of key regulatory genes in the pathogenesis of COVID-19 and sepsis: An observational study

Identification of shared pathogenetic mechanisms between COVID-19 and IC through bioinformatics and system biology

Discovering Common Pathogenetic Processes Between COVID-19 and Tuberculosis by Bioinformatics and System Biology Approach

Discovering common pathogenetic processes between tuberculosis and COVID-19 by bioinformatics and system biology approach

Bioinformatics Analysis for Identifying Pertinent Pathways and Genes in Sepsis

Bioinformatics analyses of gene expression profile to identify pathogenic mechanisms for COVID-19 infection and cutaneous lupus erythematosus

Exploring Potential Biomarkers and Molecular Mechanisms of Ischemic Cardiomyopathy and COVID-19 Comorbidity Based on Bioinformatics and Systems Biology

A Study of Differential Circrna and Lncrna Expressions in COVID-19-infected Peripheral Blood

The unfolded protein response pathway as a possible link in the pathogenesis of COVID-19 and sepsis

Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients

Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease

Integrated Bioinformatics Exploration and Preliminary Clinical Verification for the Identification of Crucial Biomarkers in Severe Cases of COVID-19

Exploring the biomarkers and potential therapeutic drugs for sepsis via integrated bioinformatic analysis

Investigation of the relationship between COVID-19 and pancreatic cancer using bioinformatics and systems biology approaches

Identification of Immune-Related Genes Concurrently Involved in Critical Illnesses Across Different Etiologies: A Data-Driven Analysis

A Bioinformatic Approach Based on Systems Biology to Determine the Effects of SARS-CoV-2 Infection in Patients with Hypertrophic Cardiomyopathy

The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis

Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection